-
Je něco špatně v tomto záznamu ?
A pilot study on the feasibility of European harmonized human biomonitoring: Strategies towards a common approach, challenges and opportunities
L. Casteleyn, B. Dumez, K. Becker, M. Kolossa-Gehring, E. Den Hond, G. Schoeters, A. Castaño, HM. Koch, J. Angerer, M. Esteban, K. Exley, O. Sepai, L. Bloemen, M. Horvat, LE. Knudsen, A. Joas, R. Joas, P. Biot, G. Koppen, MC. Dewolf, A....
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
Odkazy
PubMed
25746298
DOI
10.1016/j.envres.2014.10.028
Knihovny.cz E-zdroje
- MeSH
- biologické markery analýza MeSH
- environmentální zdraví metody MeSH
- interpretace statistických dat MeSH
- lidé MeSH
- mezinárodní spolupráce * MeSH
- monitorování životního prostředí metody MeSH
- pilotní projekty MeSH
- rozvoj plánování * MeSH
- studie proveditelnosti MeSH
- vystavení vlivu životního prostředí analýza MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Evropa MeSH
In 2004 the European Commission and Member States initiated activities towards a harmonized approach for Human Biomonitoring surveys throughout Europe. The main objective was to sustain environmental health policy by building a coherent and sustainable framework and by increasing the comparability of data across countries. A pilot study to test common guidelines for setting up surveys was considered a key step in this process. Through a bottom-up approach that included all stakeholders, a joint study protocol was elaborated. From September 2011 till February 2012, 17 European countries collected data from 1844 mother-child pairs in the frame of DEMOnstration of a study to COordinate and Perform Human Biomonitoring on a European Scale (DEMOCOPHES).(1) Mercury in hair and urinary cadmium and cotinine were selected as biomarkers of exposure covered by sufficient analytical experience. Phthalate metabolites and Bisphenol A in urine were added to take into account increasing public and political awareness for emerging types of contaminants and to test less advanced markers/markers covered by less analytical experience. Extensive efforts towards chemo-analytical comparability were included. The pilot study showed that common approaches can be found in a context of considerable differences with respect to experience and expertize, socio-cultural background, economic situation and national priorities. It also evidenced that comparable Human Biomonitoring results can be obtained in such context. A European network was built, exchanging information, expertize and experiences, and providing training on all aspects of a survey. A key challenge was finding the right balance between a rigid structure allowing maximal comparability and a flexible approach increasing feasibility and capacity building. Next steps in European harmonization in Human Biomonitoring surveys include the establishment of a joint process for prioritization of substances to cover and biomarkers to develop, linking biomonitoring surveys with health examination surveys and with research, and coping with the diverse implementations of EU regulations and international guidelines with respect to ethics and privacy.
Centre de Recherche Public Gabriel Lippmann Luxembourg
Environmental Health Center Romania
Environmental Health Sciences International The Netherlands
Faculdade de Medicina de Lisboa Portugal
Federal Environment Agency Germany
Federal Office of Public Health Switzerland
Federal Public Service Health Food chain safety and Environment Belgium
Hainaut Vigilance Sanitaire Belgium
Health Service Executive Ireland
Institute of Environmental Medicine Karolinska Institutet Stockholm Sweden
Instituto de Salud Carlos 3 Spain
Jožef Stefan Institute Slovenia
Kobenhavns Universitet Denmark
Laboratoire National de Santé Luxembourg
National Institute of Environmental Health Hungary
National Institute of Public Health Czech Republic
Nofer Institute of Occupational Medicine Poland
Public Health England United Kingdom
Ruhr Universität Bochum Germany
State General Laboratory Cyprus
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16000237
- 003
- CZ-PrNML
- 005
- 20200121091723.0
- 007
- ta
- 008
- 160108s2015 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.envres.2014.10.028 $2 doi
- 035 __
- $a (PubMed)25746298
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Casteleyn, L $u KU Leuven, Belgium. Electronic address: Ludwine.Casteleyn@med.kuleuven.be.
- 245 12
- $a A pilot study on the feasibility of European harmonized human biomonitoring: Strategies towards a common approach, challenges and opportunities / $c L. Casteleyn, B. Dumez, K. Becker, M. Kolossa-Gehring, E. Den Hond, G. Schoeters, A. Castaño, HM. Koch, J. Angerer, M. Esteban, K. Exley, O. Sepai, L. Bloemen, M. Horvat, LE. Knudsen, A. Joas, R. Joas, P. Biot, G. Koppen, MC. Dewolf, A. Katsonouri, A. Hadjipanayis, M. Cerná, A. Krsková, G. Schwedler, U. Fiddicke, JK. Nielsen, JF. Jensen, P. Rudnai, S. Közepésy, M. Mulcahy, R. Mannion, AC. Gutleb, ME. Fischer, D. Ligocka, M. Jakubowski, MF. Reis, S. Namorado, IR. Lupsa, AE. Gurzau, K. Halzlova, M. Jajcaj, D. Mazej, J. Tratnik Snoj, M. Posada, E. López, M. Berglund, K. Larsson, A. Lehmann, P. Crettaz, D. Aerts,
- 520 9_
- $a In 2004 the European Commission and Member States initiated activities towards a harmonized approach for Human Biomonitoring surveys throughout Europe. The main objective was to sustain environmental health policy by building a coherent and sustainable framework and by increasing the comparability of data across countries. A pilot study to test common guidelines for setting up surveys was considered a key step in this process. Through a bottom-up approach that included all stakeholders, a joint study protocol was elaborated. From September 2011 till February 2012, 17 European countries collected data from 1844 mother-child pairs in the frame of DEMOnstration of a study to COordinate and Perform Human Biomonitoring on a European Scale (DEMOCOPHES).(1) Mercury in hair and urinary cadmium and cotinine were selected as biomarkers of exposure covered by sufficient analytical experience. Phthalate metabolites and Bisphenol A in urine were added to take into account increasing public and political awareness for emerging types of contaminants and to test less advanced markers/markers covered by less analytical experience. Extensive efforts towards chemo-analytical comparability were included. The pilot study showed that common approaches can be found in a context of considerable differences with respect to experience and expertize, socio-cultural background, economic situation and national priorities. It also evidenced that comparable Human Biomonitoring results can be obtained in such context. A European network was built, exchanging information, expertize and experiences, and providing training on all aspects of a survey. A key challenge was finding the right balance between a rigid structure allowing maximal comparability and a flexible approach increasing feasibility and capacity building. Next steps in European harmonization in Human Biomonitoring surveys include the establishment of a joint process for prioritization of substances to cover and biomarkers to develop, linking biomonitoring surveys with health examination surveys and with research, and coping with the diverse implementations of EU regulations and international guidelines with respect to ethics and privacy.
- 650 _2
- $a biologické markery $x analýza $7 D015415
- 650 _2
- $a interpretace statistických dat $7 D003627
- 650 _2
- $a vystavení vlivu životního prostředí $x analýza $7 D004781
- 650 _2
- $a environmentální zdraví $x metody $7 D004782
- 650 _2
- $a monitorování životního prostředí $x metody $7 D004784
- 650 _2
- $a studie proveditelnosti $7 D005240
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a mezinárodní spolupráce $7 D007391
- 650 _2
- $a pilotní projekty $7 D010865
- 650 12
- $a rozvoj plánování $7 D016730
- 651 _2
- $a Evropa $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Dumez, B $u KU Leuven, Belgium.
- 700 1_
- $a Becker, K $u Federal Environment Agency (UBA), Germany.
- 700 1_
- $a Kolossa-Gehring, M $u Federal Environment Agency (UBA), Germany.
- 700 1_
- $a Den Hond, E $u VITO, Belgium.
- 700 1_
- $a Schoeters, G $u VITO, Belgium.
- 700 1_
- $a Castaño, A $u Instituto de Salud Carlos III, Spain.
- 700 1_
- $a Koch, H M $u Ruhr Universität Bochum, Germany.
- 700 1_
- $a Angerer, Jürgen, $d 1942- $7 mub2015862304 $u Ruhr Universität Bochum, Germany.
- 700 1_
- $a Esteban, M $u Instituto de Salud Carlos III, Spain.
- 700 1_
- $a Exley, K $u Public Health England, United Kingdom.
- 700 1_
- $a Sepai, O $u Public Health England, United Kingdom.
- 700 1_
- $a Bloemen, L $u Environmental Health Sciences International, The Netherlands.
- 700 1_
- $a Horvat, M $u Jožef Stefan Institute, Slovenia.
- 700 1_
- $a Knudsen, L E $u Kobenhavns Universitet, Denmark.
- 700 1_
- $a Joas, A $u BiPRO, Germany.
- 700 1_
- $a Joas, R $u BiPRO, Germany.
- 700 1_
- $a Biot, P $u Federal Public Service Health, Food chain safety and Environment, Belgium.
- 700 1_
- $a Koppen, G $u VITO, Belgium.
- 700 1_
- $a Dewolf, M-C $u Hainaut Vigilance Sanitaire (HVS) and Hygiene Publique in Hainaut (HPH), Belgium.
- 700 1_
- $a Katsonouri, A $u State General Laboratory, Cyprus.
- 700 1_
- $a Hadjipanayis, A $u Larnaca Hospital, Cyprus.
- 700 1_
- $a Cerná, M $u National Institute of Public Health, Czech Republic.
- 700 1_
- $a Krsková, A $u National Institute of Public Health, Czech Republic.
- 700 1_
- $a Schwedler, G $u VITO, Belgium.
- 700 1_
- $a Fiddicke, U $u VITO, Belgium.
- 700 1_
- $a Nielsen, J K S $u Kobenhavns Universitet, Denmark.
- 700 1_
- $a Jensen, J F $u Kobenhavns Universitet, Denmark.
- 700 1_
- $a Rudnai, P $u National Institute of Environmental Health, Hungary.
- 700 1_
- $a Közepésy, S $u National Institute of Environmental Health, Hungary.
- 700 1_
- $a Mulcahy, M $u Health Service Executive, Ireland.
- 700 1_
- $a Mannion, R $u Health Service Executive, Ireland.
- 700 1_
- $a Gutleb, A C $u Centre de Recherche Public - Gabriel Lippmann, Luxembourg.
- 700 1_
- $a Fischer, M E $u Laboratoire National de Santé, Luxembourg.
- 700 1_
- $a Ligocka, D $u Nofer Institute of Occupational Medicine, Poland.
- 700 1_
- $a Jakubowski, M $u Nofer Institute of Occupational Medicine, Poland.
- 700 1_
- $a Reis, M F $u Faculdade de Medicina de Lisboa, Portugal.
- 700 1_
- $a Namorado, S $u Faculdade de Medicina de Lisboa, Portugal.
- 700 1_
- $a Lupsa, I-R $u Environmental Health Center, Romania.
- 700 1_
- $a Gurzau, A E $u Environmental Health Center, Romania.
- 700 1_
- $a Halzlova, K $u Urad Verejneho Zdravotnictva Slovenskej Republiky, Slovakia.
- 700 1_
- $a Jajcaj, M $u Urad Verejneho Zdravotnictva Slovenskej Republiky, Slovakia.
- 700 1_
- $a Mazej, D $u Jožef Stefan Institute, Slovenia.
- 700 1_
- $a Tratnik Snoj, J $u Jožef Stefan Institute, Slovenia.
- 700 1_
- $a Posada, M $u Instituto de Salud Carlos III, Spain.
- 700 1_
- $a López, E $u Instituto de Salud Carlos III, Spain.
- 700 1_
- $a Berglund, M $u Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
- 700 1_
- $a Larsson, K $u Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
- 700 1_
- $a Lehmann, A $u Federal Office of Public Health (FOPH), Switzerland.
- 700 1_
- $a Crettaz, P $u Federal Office of Public Health (FOPH), Switzerland.
- 700 1_
- $a Aerts, D $u Federal Public Service Health, Food chain safety and Environment, Belgium. $7 gn_A_00001956
- 773 0_
- $w MED00001557 $t Environmental research $x 1096-0953 $g Roč. 141, č. - (2015), s. 3-14
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25746298 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160108 $b ABA008
- 991 __
- $a 20200121092100 $b ABA008
- 999 __
- $a ok $b bmc $g 1102518 $s 924443
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 141 $c - $d 3-14 $e 20150305 $i 1096-0953 $m Environmental research. Section A $n Environ Res $x MED00001557
- LZP __
- $a Pubmed-20160108